Persevere Therapeutics Inc.
CIK 2115419 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Persevere Therapeutics Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Mar 4, 2026 | D | 0002115419-26-000001 |